文献速递中枢神经肿瘤放疗姑息放疗与转移瘤

立体定向放疗联合免疫检查点抑制剂治疗脑转移的不良放疗效应预测因素

Predictors of Adverse Radiation Effect in Brain Metastasis Patients Treated With Stereotactic Radiosurgery and Immune Checkpoint Inhibitor Therapy.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2020-06-29

单中心回顾性研究纳入2013至2018年接受立体定向放疗的脑转移灶,其中1118个病灶接受免疫检查点抑制剂(ICI)治疗,886个未接受。

要点

  • ICI治疗与脑转移SRS后ARE风险升高相关(2年累积发生率4.5% vs 2.1%)。
  • 大体积转移灶及V12增加在ICI患者中与ARE风险快速上升相关。

核心结论

  • 接受ICI治疗的患者在脑转移SRS后发生ARE的风险增加,大体积转移灶风险尤其高。

研究设计与样本

  • 单中心回顾性综述,纳入2013至2018年接受SRS的1118个接受ICI治疗的脑转移灶和886个未接受ICI的转移灶,毒性分级采用CTCAE v4.0,采用竞争风险方法估计ARE累积发生率。

主要发现

  • 52个发生ARE的转移灶中,CTCAE v4分级为1级14例、2级15例、3级9例、4级14例,无5级事件。
  • 单因素分析中与ARE的sHR升高相关的因素包括ICI、转移灶体积、SRS剂量、处方等剂量线、 cavity-directed SRS和V12。
  • 在接受ICI的患者中,V12增加与ARE风险快速上升相关。

临床怎么用

  • 对接受ICI治疗的脑转移患者行SRS时,应关注ARE风险,尤其是大体积转移灶和V12较高的患者。

局限性

  • 本研究为单中心回顾性设计,可能存在选择偏倚和未测量混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Immune checkpoint inhibitor (ICI) therapy has recently been found to improve survival in patients with a number of cancers, including those with metastatic disease. There is an association of adverse radiation effect (ARE) in patients with brain metastases who have been treated with stereotactic radiosurgery (SRS) and ICIs. METHODS AND MATERIALS: Single-institution retrospective review identified 1118 brain metastases treated with SRS between 2013 and 2018 that had received ICI therapy and 886 metastases that did not receive ICI. Toxicity grading was done via the Common Terminology Criteria for Adverse Events v4.0 grading criteria. Cumulative incidence of ARE was estimated using competing risks methodology; univariate and multivariable regression models were generated to estimate the subdistribution hazard (sHR) of ARE. RESULTS: Two-year cumulative incidence of ARE was 4.5% and 2.1% in patients treated with and without ICI, respectively (Gray's P = .004). Of the 52 metastases exhibiting ARE during the follow-up period, ARE severity by Common Terminology Criteria for Adverse Events v4 was grade 1 in 14 patients, grade 2 in 15, grade 3 in 9, and grade 4 in 14. There were no grade 5 events. Factors associated with an increased sHR of ARE on univariate analysis included ICI, metastasis volume, SRS dose, prescription isodose line, cavity-directed SRS, and V12. Multivariable analysis revealed prescription isodose line (sHR 0.95, P < .01) and ICI (sHR 2.58, P < .01) as significant predictors of ARE. Increasing V12 was associated with a rapidly increasing risk of adverse radiation effect in patients who received ICI. CONCLUSIONS: Our findings suggest that patients receiving ICI have an increased risk of ARE after radiosurgery for brain metastases, with large metastases being at particularly high risk.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Helis CA, Hughes RT, Glenn CW, et al. Predictors of Adverse Radiation Effect in Brain Metastasis Patients Treated With Stereotactic Radiosurgery and Immune Checkpoint Inhibitor Therapy. Int J Radiat Oncol Biol Phys. 2020. PMID: 32615262. doi:10.1016/j.ijrobp.2020.06.057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。